December 2, 2021
PA-19-077 - Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)
NOT-AI-22-014 - Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery
National Institute of Allergy and Infectious Diseases (NIAID)
The purpose of this Notice is to inform the extramural community of the early expiration of PA-19-077 - Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed), effective immediately. The Key Dates section of the FOA has been modified to change the Expiration Date from January 8, 2022 to December 2, 2021.
Applicants are encouraged to consider applying to NOT-AI-22-014, “Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery”.
Annie Mo, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3320
Email: moa@niaid.nih.gov